Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia.

Lucchetti J, Formica V, Giuliano G, Coletta D, Gargano L, Morosetti D, Sileri P, Palmieri G, Roselli M.

Anticancer Res. 2018 Nov;38(11):6561-6564. doi: 10.21873/anticanres.13022.

PMID:
30396986
2.

Plasma and brain concentrations of doxycycline after single and repeated doses in wild-type and APP23 mice.

Lucchetti J, Fracasso C, Balducci C, Passoni A, Forloni G, Salmona M, Gobbi M.

J Pharmacol Exp Ther. 2018 Nov 5. pii: jpet.118.252064. doi: 10.1124/jpet.118.252064. [Epub ahead of print]

3.

Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt.

Formica V, Benassi M, Del Vecchio Blanco G, Doldo E, Martano L, Portarena I, Nardecchia A, Lucchetti J, Morelli C, Giudice E, Rossi P, Anselmo A, Sileri P, Sica G, Orlandi A, Santoni R, Roselli M.

Med Oncol. 2018 May 2;35(6):83. doi: 10.1007/s12032-018-1141-4.

PMID:
29721745
4.

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.

Battaglin F, Schirripa M, Buggin F, Pietrantonio F, Morano F, Boscolo G, Tonini G, Lutrino ES, Lucchetti J, Salvatore L, Passardi A, Cremolini C, Arnoldi E, Scartozzi M, Pella N, Boni L, Bergamo F, Zagonel V, Loupakis F, Lonardi S.

BMC Cancer. 2018 Jan 25;18(1):98. doi: 10.1186/s12885-018-4001-x.

5.

Brain disposition, metabolism and behavioral effects of the synthetic opioid AH-7921 in rats.

Lucchetti J, Marzo CM, Passoni A, Moro F, di Clemente A, Bagnati R, Cervo L, Gobbi M.

Neuropharmacology. 2018 May 1;133:51-62. doi: 10.1016/j.neuropharm.2018.01.023. Epub 2018 Jan 31.

PMID:
29366664
6.

Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer.

Guadagni F, Riondino S, Formica V, Del Monte G, Morelli AM, Lucchetti J, Spila A, D'Alessandro R, Della-Morte D, Ferroni P, Roselli M.

World J Gastroenterol. 2017 Jul 28;23(28):5187-5195. doi: 10.3748/wjg.v23.i28.5187.

7.

Brain Disposition of cis-para-Methyl-4-Methylaminorex (cis-4,4'-DMAR) and Its Potential Metabolites after Acute and Chronic Treatment in Rats: Correlation with Central Behavioral Effects.

Lucchetti J, Marzo CM, Passoni A, Di Clemente A, Moro F, Bagnati R, Gobbi M, Cervo L.

J Pharmacol Exp Ther. 2017 Jun;361(3):492-500. doi: 10.1124/jpet.117.240788. Epub 2017 Apr 12.

8.

Prognostic value of glycated hemoglobin in colorectal cancer.

Ferroni P, Formica V, Della-Morte D, Lucchetti J, Spila A, D'Alessandro R, Riondino S, Guadagni F, Roselli M.

World J Gastroenterol. 2016 Dec 7;22(45):9984-9993. doi: 10.3748/wjg.v22.i45.9984.

9.

A validated, sensitive HPLC-MS/MS method for quantification of cis-para-methyl-4-methylaminorex (cis-4,4'-DMAR) in rat and human plasma: application to pharmacokinetic studies in rats.

Lucchetti J, Marzo CM, Di Clemente A, Cervo L, Gobbi M.

Drug Test Anal. 2017 Jun;9(6):870-879. doi: 10.1002/dta.2052. Epub 2016 Sep 21.

PMID:
27509066
10.

Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury.

Papa S, Caron I, Erba E, Panini N, De Paola M, Mariani A, Colombo C, Ferrari R, Pozzer D, Zanier ER, Pischiutta F, Lucchetti J, Bassi A, Valentini G, Simonutti G, Rossi F, Moscatelli D, Forloni G, Veglianese P.

Biomaterials. 2016 Jan;75:13-24. doi: 10.1016/j.biomaterials.2015.10.015. Epub 2015 Oct 9.

PMID:
26474039
11.

Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.

Rocchetti M, Sala L, Rizzetto R, Staszewsky LI, Alemanni M, Zambelli V, Russo I, Barile L, Cornaghi L, Altomare C, Ronchi C, Mostacciuolo G, Lucchetti J, Gobbi M, Latini R, Zaza A.

Cardiovasc Res. 2014 Oct 1;104(1):37-48. doi: 10.1093/cvr/cvu188. Epub 2014 Aug 18.

PMID:
25139747
12.

Early activation of the kynurenine pathway predicts early death and long-term outcome in patients resuscitated from out-of-hospital cardiac arrest.

Ristagno G, Latini R, Vaahersalo J, Masson S, Kurola J, Varpula T, Lucchetti J, Fracasso C, Guiso G, Montanelli A, Barlera S, Gobbi M, Tiainen M, Pettilä V, Skrifvars MB; FINNRESUSCI Investigators.

J Am Heart Assoc. 2014 Aug 4;3(4). pii: e001094. doi: 10.1161/JAHA.114.001094.

13.

A new surface plasmon resonance-based immunoassay for rapid, reproducible and sensitive quantification of pentraxin-3 in human plasma.

Canovi M, Lucchetti J, Stravalaci M, Valentino S, Bottazzi B, Salmona M, Bastone A, Gobbi M.

Sensors (Basel). 2014 Jun 19;14(6):10864-75. doi: 10.3390/s140610864.

14.

Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury.

Papa S, Rossi F, Ferrari R, Mariani A, De Paola M, Caron I, Fiordaliso F, Bisighini C, Sammali E, Colombo C, Gobbi M, Canovi M, Lucchetti J, Peviani M, Morbidelli M, Forloni G, Perale G, Moscatelli D, Veglianese P.

ACS Nano. 2013 Nov 26;7(11):9881-95. doi: 10.1021/nn4036014. Epub 2013 Oct 18.

PMID:
24138479
15.

A mouse model of familial ALS has increased CNS levels of endogenous ubiquinol9/10 and does not benefit from exogenous administration of ubiquinol10.

Lucchetti J, Marino M, Papa S, Tortarolo M, Guiso G, Pozzi S, Bonetto V, Caccia S, Beghi E, Bendotti C, Gobbi M.

PLoS One. 2013 Jul 23;8(7):e69540. doi: 10.1371/journal.pone.0069540. Print 2013.

16.

Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis.

Montagna G, Cazzulani B, Obici L, Uggetti C, Giorgetti S, Porcari R, Ruggiero R, Mangione PP, Brambilla M, Lucchetti J, Guiso G, Gobbi M, Merlini G, Salmona M, Stoppini M, Villa G, Bellotti V.

Amyloid. 2013 Sep;20(3):173-8. doi: 10.3109/13506129.2013.803463. Epub 2013 Jun 4.

PMID:
23734692
17.

Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes.

Canovi M, Lucchetti J, Stravalaci M, Re F, Moscatelli D, Bigini P, Salmona M, Gobbi M.

Sensors (Basel). 2012 Nov 27;12(12):16420-32. doi: 10.3390/s121216420.

18.

Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study.

Obici L, Cortese A, Lozza A, Lucchetti J, Gobbi M, Palladini G, Perlini S, Saraiva MJ, Merlini G.

Amyloid. 2012 Jun;19 Suppl 1:34-6. doi: 10.3109/13506129.2012.678508. Epub 2012 May 2.

PMID:
22551192
19.

Identification of natural ligands for the orphan G protein-coupled receptors GPR7 and GPR8.

Brezillon S, Lannoy V, Franssen JD, Le Poul E, Dupriez V, Lucchetti J, Detheux M, Parmentier M.

J Biol Chem. 2003 Jan 10;278(2):776-83. Epub 2002 Oct 24.

20.

Novel heterocyclic analogues of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.

Gubin J, de Vogelaer H, Inion H, Houben C, Lucchetti J, Mahaux J, Rosseels G, Peiren M, Clinet M, Polster P, et al.

J Med Chem. 1993 May 14;36(10):1425-33.

PMID:
8496910
21.

A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.

Gubin J, Lucchetti J, Mahaux J, Nisato D, Rosseels G, Clinet M, Polster P, Chatelain P.

J Med Chem. 1992 Mar 20;35(6):981-8.

PMID:
1552511

Supplemental Content

Loading ...
Support Center